Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2740)	3/29/2010 10:22:30 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

OXBT is also having a good spike today.<g> It is still up 48.71% and volume ia almost 3x its ADV bigcharts.marketwatch.com It announced that it has begun distribution of its Dermacyte Oxygen Concentrate for the beauty and skin care market. This over-the-counter product is a perfluorocarbon concentrate to enhance oxygen delivery to skin. They said that this is the first product in a broad and diverse cosmetic line currently under development.<g> It uses OXBT's patented Oxycyte technology, an oxygen carrier designed to enhance oxygen delivery to tissues such as skin. <g> OXBT was able to trim its loss on the 2nd Q, but the pending 2Qs are not expected to show significant improvements on the bottom line.<g> The ACTAY is $15 but the stock is very speculative and I think I will just keep my 'target' at $8 <g> bigcharts.marketwatch.com Bernard